Search results
HC Wainwright Cuts Cullinan Oncology (NASDAQ:CGEM) Price Target to $28.00
ETF DAILY NEWS· 2 days agoCullinan Oncology (NASDAQ:CGEM – Free Report) had its target price decreased by HC Wainwright from $29.00 to $28.00 in a report released on Thursday morning, Benzinga reports ...
Cullinan Oncology (NASDAQ:CGEM) Stock Rating Reaffirmed by Wedbush
ETF DAILY NEWS· 3 days agoCullinan Oncology (NASDAQ:CGEM – Get Free Report)‘s stock had its “outperform” rating reissued by investment analysts at Wedbush in a research report issued to clients and ...
Earnings call: Predictive Oncology reports Q1 2024 financials, AI study By Investing.com
Investing.com· 6 days agoPredictive Oncology (Ticker: POAI) has announced its financial results for the first quarter of...
Earnings call: Predictive Oncology reports Q1 2024 financials, AI study
Investing.com· 7 days agoPredictive Oncology (Ticker: POAI) has announced its financial results for the first quarter of...
Earnings call: The Oncology Institute sees revenue climb, plans growth By Investing.com
Investing.com· 3 days agoThe Oncology Institute (TOI) has reported a significant 24% increase in revenue for the first...
Sophia Randolph Sells 12,000 Shares of ALX Oncology Holdings Inc. (NASDAQ:ALXO) Stock
ETF DAILY NEWS· 4 days agoALX Oncology Holdings Inc. (NASDAQ:ALXO – Get Free Report) insider Sophia Randolph sold 12,000 shares of the company’s stock in a transaction on Monday, May 13th. The shares ...
North Carolina biotech firm expanding corporate offices to Cleveland
Crain's Cleveland Business· 3 hours agoHanna’s brother and Lamassu’s co-founder, Dr. Rabi Hanna, is chairman of pediatric oncology at the Clinic. Hanna said the company wants to make Cleveland and the Clinic strategic ...
Eli Lilly pays Aktis $60M upfront to further dial into radiopharma signal
FierceBiotech· 5 hours agoEli Lilly is continuing to ride the radiopharma wave, paying Aktis Oncology $60 million upfront to...
Pyxis Oncology, Inc. (NASDAQ:PYXS) Sees Large Decline in Short Interest
ETF DAILY NEWS· 6 days agoPyxis Oncology, Inc. (NASDAQ:PYXS – Get Free Report) saw a large drop in short interest in the month of April. As of April 30th, there was short interest totalling 1,850,000 ...
ALX Oncology Holdings Inc. (NASDAQ:ALXO) Receives $18.83 Consensus Target Price from Analysts
ETF DAILY NEWS· 7 days agoShares of ALX Oncology Holdings Inc. (NASDAQ:ALXO – Get Free Report) have earned a consensus rating of “Moderate Buy” from the six ratings firms that are covering the stock ...